OBJECTIVE The EBNA1 IgA antibody level of normal and NPC subjects in a high incidence area were analyzed for new diagnostic criteria to improve diagnosis. METHODS A total of 780 normal and 104 NPC sera were tested for...OBJECTIVE The EBNA1 IgA antibody level of normal and NPC subjects in a high incidence area were analyzed for new diagnostic criteria to improve diagnosis. METHODS A total of 780 normal and 104 NPC sera were tested for EBNA1 IgA antibody levels by ELISA. Two diagnostic criteria were obtained from sensitivity and specificity data: 1) lower equivocal limit (rOD =1.10) where sensitivity = 95%; and 2) upper equivocal limit (rOD=1.85) where specificity = 95%. RESULTS The range and distribution of EBNA1 IgA antibody levels are broad with those of normal subjects (0.093-4.726, mean = 0.850 ± 0.637) overlapping those from NPC subjects (0.235-3.721, mean = 2.241 ± 0.875). However, NPC subjects did exhibit significantly higher antibody levels (t = 18.5, P<0.001). Based on the diagnostic criteria, 3 diagnostic categories were established: ① Positive; ② Suspected Positive; and 3) Negative. The percentage of NPC subjects falling into these 3 diagnostic categories were 75.13%, 17.44% and 7.44%, respectively and of normal subjects, 4.81%, 17.31%, 77.88% respectively. CONCLUSION Due to the broad distribution and overlapping of antibody levels between normal and NPC subjects in a high incidence area, it is important to have diagnostic criteria that will categorize those with equivocal results to minimize misdiagnosis. The 3 diagnostic categories established in this study will enhance detection and help physicians in their clinical diagnosis.展开更多
Epstein-Barr virus (EBV) infection is closely associated with nasopharyngeal carcinoma (NPC)and considered one of the major risk factors[1]. A limited number of viral proteins, such as latent membrane proteins (LMP1, ...Epstein-Barr virus (EBV) infection is closely associated with nasopharyngeal carcinoma (NPC)and considered one of the major risk factors[1]. A limited number of viral proteins, such as latent membrane proteins (LMP1, LMP2) and EB nuclear antigen1 (EBNA1), are expressed in NPC cells[2].Recognition epitopes for CD8+and CD4+T cells were included in the LMP2 antigen and EBNA1 C-terminal region (amino acid No. 380-641), respectively[3,4].Both CD4+and CD8+memory T-cell responses were efficiently reactivated by EBNA1 and LMP2[5;6].展开更多
Objective To investigate the combination of Epstein-Barr virus nuclear protein 3C (EBNA3C) with Gemin3 and its effect on Gemin3 expression. Methods Co-immunoprecipitation, GST pull-down and immunofluorescent assay wer...Objective To investigate the combination of Epstein-Barr virus nuclear protein 3C (EBNA3C) with Gemin3 and its effect on Gemin3 expression. Methods Co-immunoprecipitation, GST pull-down and immunofluorescent assay were used to determine the combination of EBNA3C and Gemin3 and their combining domain. Stable EBNA3C knockdown cell lines were made by lentivirus-delivered small hairpin RNA and then puromycin selection. Western blot was used to check the effect of EBNA3C on Gemin3 expression. Results EBNA3C and Gemin3 combined with each other in vivo and in vitro through their C-terminals. EBNA3C up-regulated Gemin3 gene expression. Conclusion EBNA3C forms complex with Gemin3 and up-regulates its expression.展开更多
用转染EBV DNA Bam HI K片段后稳定表达EBNA-1的K_4细胞作为靶细胞,检测50份鼻咽癌病人和38份健康对照者血清中的IgG/EBNA-1抗体;阳性率分别为100％和92％。前者的平均几何滴度为89.4,后者为18.3,前者约为后者的5倍。同一批被检血清经SP...用转染EBV DNA Bam HI K片段后稳定表达EBNA-1的K_4细胞作为靶细胞,检测50份鼻咽癌病人和38份健康对照者血清中的IgG/EBNA-1抗体;阳性率分别为100％和92％。前者的平均几何滴度为89.4,后者为18.3,前者约为后者的5倍。同一批被检血清经SPA吸收去除IgG竞争性抑制后,鼻咽癌病人的IgA/EBNA-1抗体阳性率达78％(GMT 20.9),健康人的IgA/EBNA-1抗体阳性率仅5.3％,效价亦很低(GMT 5.2)。表明IgA/EBNA-1抗体对鼻咽癌是比较特异的,可考虑作为鼻咽癌血清学诊断的指标之一。展开更多
文摘OBJECTIVE The EBNA1 IgA antibody level of normal and NPC subjects in a high incidence area were analyzed for new diagnostic criteria to improve diagnosis. METHODS A total of 780 normal and 104 NPC sera were tested for EBNA1 IgA antibody levels by ELISA. Two diagnostic criteria were obtained from sensitivity and specificity data: 1) lower equivocal limit (rOD =1.10) where sensitivity = 95%; and 2) upper equivocal limit (rOD=1.85) where specificity = 95%. RESULTS The range and distribution of EBNA1 IgA antibody levels are broad with those of normal subjects (0.093-4.726, mean = 0.850 ± 0.637) overlapping those from NPC subjects (0.235-3.721, mean = 2.241 ± 0.875). However, NPC subjects did exhibit significantly higher antibody levels (t = 18.5, P<0.001). Based on the diagnostic criteria, 3 diagnostic categories were established: ① Positive; ② Suspected Positive; and 3) Negative. The percentage of NPC subjects falling into these 3 diagnostic categories were 75.13%, 17.44% and 7.44%, respectively and of normal subjects, 4.81%, 17.31%, 77.88% respectively. CONCLUSION Due to the broad distribution and overlapping of antibody levels between normal and NPC subjects in a high incidence area, it is important to have diagnostic criteria that will categorize those with equivocal results to minimize misdiagnosis. The 3 diagnostic categories established in this study will enhance detection and help physicians in their clinical diagnosis.
基金supported by the Mega Project of Research on the Prevention and Control of HIV/AIDS,Viral Hepatitis Infectious Diseases [2018ZX10711001]
文摘Epstein-Barr virus (EBV) infection is closely associated with nasopharyngeal carcinoma (NPC)and considered one of the major risk factors[1]. A limited number of viral proteins, such as latent membrane proteins (LMP1, LMP2) and EB nuclear antigen1 (EBNA1), are expressed in NPC cells[2].Recognition epitopes for CD8+and CD4+T cells were included in the LMP2 antigen and EBNA1 C-terminal region (amino acid No. 380-641), respectively[3,4].Both CD4+and CD8+memory T-cell responses were efficiently reactivated by EBNA1 and LMP2[5;6].
文摘Objective To investigate the combination of Epstein-Barr virus nuclear protein 3C (EBNA3C) with Gemin3 and its effect on Gemin3 expression. Methods Co-immunoprecipitation, GST pull-down and immunofluorescent assay were used to determine the combination of EBNA3C and Gemin3 and their combining domain. Stable EBNA3C knockdown cell lines were made by lentivirus-delivered small hairpin RNA and then puromycin selection. Western blot was used to check the effect of EBNA3C on Gemin3 expression. Results EBNA3C and Gemin3 combined with each other in vivo and in vitro through their C-terminals. EBNA3C up-regulated Gemin3 gene expression. Conclusion EBNA3C forms complex with Gemin3 and up-regulates its expression.
文摘用转染EBV DNA Bam HI K片段后稳定表达EBNA-1的K_4细胞作为靶细胞,检测50份鼻咽癌病人和38份健康对照者血清中的IgG/EBNA-1抗体;阳性率分别为100％和92％。前者的平均几何滴度为89.4,后者为18.3,前者约为后者的5倍。同一批被检血清经SPA吸收去除IgG竞争性抑制后,鼻咽癌病人的IgA/EBNA-1抗体阳性率达78％(GMT 20.9),健康人的IgA/EBNA-1抗体阳性率仅5.3％,效价亦很低(GMT 5.2)。表明IgA/EBNA-1抗体对鼻咽癌是比较特异的,可考虑作为鼻咽癌血清学诊断的指标之一。
